Publication Information

{'id': 'https://openalex.org/W2000433012', 'doi': 'https://doi.org/10.1097/00001813-199801000-00001', 'title': 'Preclinical pharmacokinetics of paclitaxel and docetaxel', 'display_name': 'Preclinical pharmacokinetics of paclitaxel and docetaxel', 'publication_year': 1998, 'publication_date': '1998-01-01', 'ids': {'openalex': 'https://openalex.org/W2000433012', 'doi': 'https://doi.org/10.1097/00001813-199801000-00001', 'mag': '2000433012', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/9491787'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001813-199801000-00001', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S158028025', 'display_name': 'Anti-Cancer Drugs', 'issn_l': '0959-4973', 'issn': ['0959-4973', '1473-5741'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5065279964', 'display_name': 'Alex Sparreboom', 'orcid': 'https://orcid.org/0000-0003-2660-6644'}, 'institutions': [{'id': 'https://openalex.org/I907135538', 'display_name': 'Rotterdam University of Applied Sciences', 'ror': 'https://ror.org/0481e1q24', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I907135538']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Alex Sparreboom', 'raw_affiliation_strings': ['Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: (+31) 10 4391754', 'Fax: (+31) 10 4851618'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel: (+31) 10 4391754', 'institution_ids': ['https://openalex.org/I907135538']}, {'raw_affiliation_string': 'Fax: (+31) 10 4851618', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034151807', 'display_name': 'Olaf van Tellingen', 'orcid': 'https://orcid.org/0000-0002-1037-6269'}, 'institutions': [{'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Olaf van Tellingen', 'raw_affiliation_strings': ['Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I2898336195']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113557752', 'display_name': 'Willem J. Nooijen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Willem J. Nooijen', 'raw_affiliation_strings': ['Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Chemistry, Antoni van Leeuwenhoek Huis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I2898336195']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5062227574', 'display_name': 'Jos H. Beijnen', 'orcid': 'https://orcid.org/0000-0003-0118-561X'}, 'institutions': [{'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}, {'id': 'https://openalex.org/I2802065108', 'display_name': 'Slotervaartziekenhuis', 'ror': 'https://ror.org/01w502745', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802065108']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Jos H. Beijnen', 'raw_affiliation_strings': ['Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands', 'Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6,1066 EC, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands', 'institution_ids': ['https://openalex.org/I193662353']}, {'raw_affiliation_string': 'Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6,1066 EC, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I2802065108']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.347, 'has_fulltext': False, 'cited_by_count': 145, 'citation_normalized_percentile': {'value': 0.998238, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '9', 'issue': '1', 'first_page': '1', 'last_page': '17'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.9909, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10073', 'display_name': 'Hepatocellular Carcinoma Treatment and Prognosis', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2781190966', 'wikidata': 'https://www.wikidata.org/wiki/Q420436', 'display_name': 'Docetaxel', 'level': 3, 'score': 0.94474024}, {'id': 'https://openalex.org/C2777292972', 'wikidata': 'https://www.wikidata.org/wiki/Q423762', 'display_name': 'Paclitaxel', 'level': 3, 'score': 0.90559196}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.8283697}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.593621}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.57916194}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.35068455}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26555133}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.23390868}], 'mesh': [{'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D043823', 'descriptor_name': 'Taxoids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000972', 'descriptor_name': 'Antineoplastic Agents, Phytogenic', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D000077143', 'descriptor_name': 'Docetaxel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005243', 'descriptor_name': 'Feces', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005243', 'descriptor_name': 'Feces', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D015394', 'descriptor_name': 'Molecular Structure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017239', 'descriptor_name': 'Paclitaxel', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D011485', 'descriptor_name': 'Protein Binding', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014018', 'descriptor_name': 'Tissue Distribution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001813-199801000-00001', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S158028025', 'display_name': 'Anti-Cancer Drugs', 'issn_l': '0959-4973', 'issn': ['0959-4973', '1473-5741'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9491787', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3011485962', 'https://openalex.org/W2367553917', 'https://openalex.org/W2348179556', 'https://openalex.org/W2132924838', 'https://openalex.org/W2101100140', 'https://openalex.org/W2071247880', 'https://openalex.org/W2065556081', 'https://openalex.org/W2000433012', 'https://openalex.org/W1990296886', 'https://openalex.org/W1980931076'], 'abstract_inverted_index': {'The': [0, 40, 129], 'taxanes': [1], 'paclitaxel': [2, 50, 98, 181, 192], 'and': [3, 23, 52, 70, 86, 147, 156, 182, 210, 225], 'docetaxel': [4, 56, 71, 148, 198], 'represent': [5], 'a': [6, 31, 73, 94, 226], 'novel': [7], 'class': [8], 'of': [9, 15, 26, 37, 46, 76, 83, 88, 97, 127, 134, 154, 180, 223, 229], 'antineoplastic': [10], 'agents.': [11], 'A': [12], 'major': [13, 110, 221, 227], 'problem': [14], 'both': [16, 135, 205, 215], 'drugs': [17], 'is': [18, 79, 187, 194, 200, 219, 232], 'their': [19, 184], 'low': [20, 163], 'aqueous': [21], 'solubility': [22], 'the': [24, 35, 109, 114, 125, 168, 173, 177, 220, 230], 'design': [25], 'suitable': [27], 'formulations': [28, 41], 'has': [29], 'been': [30, 63], 'difficult': [32], 'step': [33], 'in': [34, 99, 113, 124, 142, 167, 176, 204, 211, 234], 'process': [36], 'therapeutic': [38], 'development.': [39], 'currently': [42], 'used': [43], 'are': [44, 66], 'mixtures': [45], 'Cremophor': [47, 107], 'EL:ethanol': [48], 'for': [49, 55], '(Taxol)': [51], 'Tween': [53], '80:ethanol': [54], '(Taxotere),': [57], 'but': [58, 161], 'many': [59], 'new': [60], 'approaches': [61], 'have': [62, 72], 'tested': [64], 'or': [65, 239], 'under': [67], 'investigation.': [68], 'Paclitaxel': [69, 146], 'similar': [74, 201], 'mechanism': [75], 'action,': [77], 'which': [78, 101], 'based': [80], 'on': [81], 'promotion': [82], 'tubulin': [84], 'assembly': [85], 'inhibition': [87], 'microtubule': [89], 'disassembly.': [90], 'Pharmacokinetic': [91], 'studies': [92], 'revealed': [93], 'marked': [95], 'non-linearity': [96], 'mice,': [100], 'appeared': [102], 'to': [103, 140], 'result': [104], 'exclusively': [105], 'from': [106, 138], 'EL,': [108], 'component': [111], 'present': [112], 'pharmaceutical': [115], 'formulation.': [116], 'An': [117], 'almost': [118], 'linear': [119], 'pharmacokinetic': [120], 'behavior': [121], 'was': [122], 'observed': [123], 'case': [126], 'docetaxel.': [128], 'reported': [130], 'plasma': [131], 'protein': [132], 'binding': [133], 'compounds': [136], 'ranged': [137], '76': [139], '97%': [141], 'different': [143], 'animal': [144], 'species.': [145], 'widely': [149], 'distribute': [150], 'into': [151], 'most': [152], 'tissues': [153], 'mice': [155], 'rats,': [157], 'including': [158], 'tumor': [159], 'tissue,': [160], 'only': [162], 'concentrations': [164], 'were': [165], 'detected': [166], 'central': [169], 'nervous': [170], 'system.': [171], 'Despite': [172], 'great': [174], 'similarity': [175], 'chemical': [178], 'structures': [179], 'docetaxel,': [183], 'metabolic': [185], 'profile': [186], 'very': [188], 'distinct.': [189], 'Furthermore,': [190], 'whereas': [191], 'metabolism': [193, 199], 'largely': [195], 'species': [196, 203], 'dependent,': [197], 'across': [202], 'isolated': [206], 'hepatic': [207], 'microsomal': [208], 'fractions': [209], 'vivo': [212], 'models.': [213], 'For': [214], 'taxanes,': [216], 'hepatobiliary': [217], 'excretion': [218], 'pathway': [222], 'elimination': [224], 'fraction': [228], 'dose': [231], 'excreted': [233], 'feces': [235], 'as': [236], 'parent': [237], 'drug': [238], 'hydroxylated': [240], 'metabolites.': [241]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2000433012', 'counts_by_year': [{'year': 2024, 'cited_by_count': 6}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 7}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 10}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 8}], 'updated_date': '2025-01-02T22:09:59.694508', 'created_date': '2016-06-24'}